The evolution of cell therapy to address unmet medical needs

Published on August 7, 2024

Cell and gene therapies (C>s) enjoyed “a landmark close” to 2023 and continued its momentum in Q1 2024 with “several notable approvals and strong growth in all stages of clinical development”, according to the latest quarterly Gene, Cell & RNA Therapy Landscape Report by Citeline in association with the American Society of Cell & Gene […]

Continue reading on website
Other news

The Medicine Maker: Navigating the Challenges and Complexities of ADC Development

August 5, 2024
In The Medicine Maker’s latest article, Erika Kovacs, Senior Director of Bioassays at Abzena, dives into the complex landscape of Antibody-Drug Conjugate (ADC) development. Kovacs explores the unique challenges in ADC design, production, and regulatory compliance and highlights innovative strategies to address these hurdles.In the intricate and highly specialized arena of targeted oncology therapi

Wayspring Celebrates Expansion with Wellpoint Tennessee

August 8, 2024
Wayspring Celebrates Expansion with Wellpoint Tennessee, Marking a New Chapter in Longstanding Commitment to Substance Use RecoveryNASHVILLE, Tenn. – Wayspring, a leader in providing comprehensive substance use disorder (SUD) care, proudly announces the significant expansion of its services for Wellpoint Tennessee, Inc. (Wellpoint) members. This expansion not only reflects Wayspring’s commitment t